Compare · LFST vs OPCH
LFST vs OPCH
Side-by-side comparison of LifeStance Health Group Inc. (LFST) and Option Care Health Inc. (OPCH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both LFST and OPCH operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- LFST is the larger of the two at $4.15B, about 1.2x OPCH ($3.39B).
- Over the past year, LFST is up 138.5% and OPCH is down 29.3% - LFST leads by 167.8 points.
- LFST has been more active in the news (11 items in the past 4 weeks vs 3 for OPCH).
- LFST has more recent analyst coverage (17 ratings vs 15 for OPCH).
- Company
- LifeStance Health Group Inc.
- Option Care Health Inc.
- Price
- $10.88+1.59%
- $21.69+0.60%
- Market cap
- $4.15B
- $3.39B
- 1M return
- +38.18%
- +1.47%
- 1Y return
- +138.49%
- -29.30%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- News (4w)
- 11
- 3
- Recent ratings
- 17
- 15
LifeStance Health Group Inc.
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics. It offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. The company offers patients care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was incorporated in 2021 and is based in Scottsdale, Arizona.
Option Care Health Inc.
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides immunoglobulin infusion therapies for the treatment of immune deficiencies; anti-infective therapies and services; home infusion services to treat heart failures; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders; and immunoglobulin infusion therapies. It also offers infusion therapies for bleeding disorders; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications. In addition, the company offers therapies that women need to survive and thrive through high-risk pregnancies; treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; and nursing services. The company is headquartered in Bannockburn, Illinois.
Latest LFST
- Director Palmer Eric P was granted 17,746 shares, increasing direct ownership by 25% to 89,174 units (SEC Form 4)
- Director Bessler Robert was granted 17,746 shares, increasing direct ownership by 31% to 75,365 units (SEC Form 4)
- Director Personette Sarah was granted 17,746 shares, increasing direct ownership by 24% to 92,512 units (SEC Form 4)
- Director Deluca Teresa was granted 17,746 shares, increasing direct ownership by 17% to 125,034 units (SEC Form 4)
- Director Justice Thurman was granted 35,492 shares (SEC Form 4)
- Director Goltermann Lori was granted 35,492 shares (SEC Form 4)
- SEC Form 3 filed by new insider Goltermann Lori
- SEC Form 3 filed by new insider Justice Thurman
- SEC Form 3 filed by new insider Shabab Safwan
- SEC Form 8-K filed by LifeStance Health Group Inc.
Latest OPCH
- Option Care Health to Announce Second Quarter 2026 Financial Results and Host Conference Call
- EVP Sp Sales & Solutions Bhatia Prateek was granted 39,795 shares (SEC Form 4)
- SEC Form 3 filed by new insider Bhatia Prateek
- Goldman initiated coverage on Option Care Health with a new price target
- Option Care Health Appoints Robert Okunski as Vice President, Investor Relations
- Option Care Health Awarded TIME's World's Most Impactful Companies 2026 Ranking
- Director Bierbower Elizabeth D was granted 8,997 shares, increasing direct ownership by 38% to 32,871 units (SEC Form 4)
- Director Deckmann Natasha was granted 9,841 shares, increasing direct ownership by 44% to 32,002 units (SEC Form 4)
- Director Kraemer Harry M Jansen Jr was granted 21,076 shares, increasing direct ownership by 5% to 471,076 units (SEC Form 4)
- Director Pate R Carter was granted 8,997 shares, increasing direct ownership by 77% to 20,620 units (SEC Form 4)